Suanfarma Suanfarma

X

Find Radio Compass News for Idarubicin Hydrochloride

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables

Joseph Keenan FIERCEPHARMA
24 May 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-20-2022-1650431289.pdf

FDA
20 Apr 2022

https://www.fiercepharma.com/pharma/teva-recalls-one-lot-leukemia-med-after-discovering-injectable-drugs-nemesis-particulates

F. Kansteiner FIERCEPHARMA
31 Mar 2022

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-issues-voluntary-nationwide-recall-one-lot-idarubicin-hydrochloride-injection-usp-5-mg5-ml-due

FDA
30 Mar 2022

https://www.europeanpharmaceuticalreview.com/news/165376/drug-combination-an-alternative-leukaemia-treatment-to-chemotherapy/

Anna Begley EUROPEANPHARMACEUTICALREVIEW
12 Nov 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf

FDA
25 Aug 2021

https://www.oncnet.com/news/decitabine-plus-chemo-denotes-new-induction-therapy-option-aml-mds-features

ONCNET
17 Mar 2019
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY